Featuring BioEclosion cartridge in biosensing research in breast cancer detection based on exosomes
Transforming Breast Cancer Diagnosis. BioEclosion’s breakthrough in biosensing technology In …
WORLDWIDE SOLUTIONS
Next generation of rapid diagnostic test for low-resource settings to solve the societal challenge of global health.
Patented magneto-actuated biosensors deliver quantitative results in 10 minutes straight to your smartphone.
Powered by a patented point-of-care IVD platform, BioEclosion delivers lab-grade results in ten minutes across human, veterinary and food-safety markets. A three-pronged revenue model—technology licensing, high-margin cartridge sales and strategic co-development partnerships—promises investors swift growth and resilient long-term returns.
Our global laboratories can provide diagnostics solutions for clinical trials across America, Europe and Asia.
9dok services can quickly deliver the information you and your doctor need for your most important health decisions.
With specialist research groups research at 9dok focuses on structural biology and molecular cell biology.
We constantly upgrade and implement the latest technologies in our laboratory procedures to ensure delivery of perfect health care.
9dok Diagnostics is devoted to render exceptional services in terms of care and producing error-free results. Our accreditation with NABL validates our commitment and services.
We render quality and high-standard services to our customers to ensure supremacy at every stage. We have been accredited by NABL, National Accreditation Board for Testing and Collaboration Laboratories.
Our self motivated and dedicated team of doctors has a major role to play in our success and growth and has provided us with an opportunity to deliver outstanding services.
Our dedication and passion for rendering extraordinary services to our patients have made us gain the trust of 4 million.ns
Our pioneering, completely-automated laboratory is furnished with the latest infrastructure.
ABOUT BIOECLOSION
Transforming Breast Cancer Diagnosis. BioEclosion’s breakthrough in biosensing technology In …
At Bioeclosion, the last month of 2024 has been truly …
Dr. Jofre Ferrer-Dalmau, CEO of BioEclosion, has recently participated in …
Each disposable cartridge contains DNA/RNA probes or immunoreagents attached to magnetic micro-particles. When the cartridge is inserted, an internal magnet concentrates the particles onto a screen-printed electrode; the reader then converts the electro-chemical signal into a quantitative read-out. This magneto-actuated, electrochemical approach eliminates the fluid flow of lateral-flow strips and the thermal cycling of PCR while retaining high analytical performance.
The system has only two elements: a single-use plastic cartridge (pre-loaded with dried reagents) and a portable, battery-operated reader that can be reused indefinitely with different cartridges. No calibration or external instruments are required.
Viral or protein targets (e.g., Avian Influenza, NDV, IBV) are designed for a ≤ 15-minute turnaround. • The AmpliFast molecular cartridge for neonatal Streptococcus agalactiae (GBS) delivers a result within ~30 minutes, thanks to isothermal amplification inside the cartridge. * Ejemplo de rendimiento: detección de Mycobacterium con LOD = 5 CFU mL⁻¹, 1 000× más sensible que los cribados rápidos convencionales.
Poultry farm pools → AIV, NDV, IBV; Neonatal blood/CSF and maternal swabs → GBS; Human serum → breast-cancer-derived exosomes; Future pipeline → fever-severity biomarkers for pediatrics.
Yes. The reader is diagnostic-agnostic; switching to a new pathogen only requires loading the cartridge with alternative probes. The AviaSenS consortium explicitly describes the vision of “an agnostic platform capable of quantifying various communicable diseases … easily switched to emerging challenges.
The same hardware supports human health (primary care, neonatology), veterinary diagnostics (on-farm outbreak screening), food safety, and environmental surveillance. Projects highlight use in both resource-limited settings and high-income countries to shorten turnaround times and reduce costs.
Intermountain Healthcare is contracted with the majority of insurance plans for laboratory testing. These insurance plans cover the most commonly ordered lab tests. If you have a question about specific tests your physician has ordered, please contact your insurance carrier. Your physician’s billing office may also be able to tell you what out-of-pocket expenses there may be, if any.
BioEclosion holds a multi-jurisdiction patent family, e.g., “Peptide, magnetic peptide and method for detecting celiac disease” filed in Europe, the USA, Canada, and via PCT. Devices are being developed under ISO 13485 and IVDR guidance to streamline future CE-marking.
NEED MORE INFORMATION?
Input your search keywords and press Enter.
To provide the best experiences, we use technologies such as cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent may adversely affect certain features and functions.